Sohnle P G, Collins-Lech C
J Invest Dermatol. 1980 Sep;75(3):279-83. doi: 10.1111/1523-1747.ep12523548.
In lymphocyte transformation studies using optimal concentrations of P. orbiculare and C. albicans extracts, positive responses were found in 31 of 32 normal human subjects to the former and 44 of 49 to the latter. The overall degree of sensitivity to extracts of the 2 organisms as judged by stimulation ratios was not significantly different. The organisms did not appear to cross-react in lymphocyte transformation tests, and in individual human subjects tested with both organisms, a strong response to one did not correlate with a strong response to the other. Extracts of neither organism contained substances suppressive of lymphocyte transformation. P. orbiculare extracts appeared to be significantly less antigenic than those of C. albicans, whether tested against naturally-sensitized humans or artificially-sensitized guinea pigs even though the same amount of protein was extractable from each organism. Therefore, these studies indicate that P. orbiculare has been as successful as C. albicans in producing sensitization against its antigens in the general human population. However, P. orbiculare appears to be significantly less antigenic than is C. albicans, a finding which might be related to the relative lack of inflammation in lesions produced by P. orbiculare, and the rather high incidence of chronic tinea versicolor as compared to chronic mucocutaneous candidiasis.
在使用最佳浓度的圆形马拉色菌和白色念珠菌提取物进行的淋巴细胞转化研究中,32名正常人类受试者中有31名对前者有阳性反应,49名中有44名对后者有阳性反应。根据刺激率判断,对这两种生物体提取物的总体敏感程度没有显著差异。在淋巴细胞转化试验中,这两种生物体似乎没有交叉反应,并且在同时用这两种生物体进行测试的个体人类受试者中,对一种生物体的强烈反应与对另一种生物体的强烈反应没有相关性。两种生物体的提取物都不含有抑制淋巴细胞转化的物质。无论针对自然致敏的人类还是人工致敏的豚鼠进行测试,即使从每种生物体中可提取的蛋白质量相同,圆形马拉色菌提取物的抗原性似乎也明显低于白色念珠菌提取物。因此,这些研究表明,圆形马拉色菌在普通人群中产生针对其抗原的致敏方面与白色念珠菌一样成功。然而,圆形马拉色菌的抗原性似乎明显低于白色念珠菌,这一发现可能与圆形马拉色菌引起的病变中相对缺乏炎症有关,也与花斑癣慢性病的发病率较高而慢性黏膜皮肤念珠菌病的发病率较低有关。